DUBLIN, October 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Antiemetic Drugs Market Analysis: By Type of Drug (5-HT3 receptor antagonists, Dopamine antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 receptor antagonist, Antihistamines, Cannabinoids); By Applications With Forecast (2016-2021)" report to their offering.
An increasing number of people being affected with different types of cancer is another factor driving the growth of the antiemetic drug market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomitting. In fact, chemotherapy actually accounts for the largest share of all the applications of the global antiemetic drugs market.
Antiemetic drugs are those that have the ability to treat conditions such as nausea and vomitting. They can be used to treat the aforementioned conditions caused by a range of illnesses. Chemotherapy for cancer patients, food poisoning, gastroenteritis, motion sickness and so on can be treated by antiemetic drugs. In case of pregnant women, these drugs bring significant relief to women who have to endure bouts of morning sickness, either during the early phase of the pregnancy. For some women, the morning sickness lasts for much longer and antiemetic drugs are extremely useful in such situations.
The time to market and the limited resources for clinical trials and animal testing a factors that are inhibiting the growth of this market. There is a lot of funding devoted to research and development efforts and this can negate some of the growth inhibitors of the antiemetic drug market.
The Antiemetic Drugs market can be segmented on the basis of type of drug as:
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
In terms of applications, the Antiemetic Drugs market has been segmented across the following:
- Motion Sickness
- Food Poisoning
- General Anesthetics
- Opiod Analgesics
- Emotional Stress
North America followed by Europe currently dominate the global antiemetic drugs market and this trend is anticipated to hold good till the end of the forecast period considered in this report. In Asia Pacific, the rapidly increasing population has the potential to further the growth of this market. There is also a general increase in several lifestyle related diseases across the world and this can also potentially drive the growth of this market.
The following are just a few of the companies that are operating in the Antiemetic Drugs market:
- Baxter International
- Novartis AG
- Johnson and Johnson
- GlaxoSmithKline Plc
- Cipla Ltd.
1. Antiemetic Drugs Market Overview
2. Executive Summary
3. Antiemetic Drugs Market Landscape
4. Antiemetic Drugs Market Forces
5. Antiemetic Drugs Market - Strategic Analysis
6. Antiemetic Drugs Market By Type of Drug
7. Antiemetic Drugs Market By Application
8. Antiemetic Drugs Market By Geography
9. Antiemetic Drugs Market Entropy
10. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/cr8fw8/antiemetic_drugs
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-antiemetic-drugs-market-analysis---trends-technologies--opportunities-report-2016-2021---vendors-cipla-glaxosmithkline-novartis-300345821.html
SOURCE Research and Markets